No business is safe from a cyberattack, which is why more companies, large and small, are taking out cybersecurity insurance policies.» Read More
Reporters could only listen to Pfizer's hastily-organized "Investor Luncheon," so I can't tell you how many people showed up or what the room looked like. But Chairman and CEO Jeff Kindler drew a pretty good picture at the start of his opening remarks.
This is the first paragraph/short story.
A few days into his term, President Obama appears to have begun to undo another Bush-era policy. He hasn't yet formally lifted the Bush-imposed ban on federal funding of new embryonic stem cell research, but Obama's Food and Drug Administration has already set the stage for it.
For years pharmaceutical companies and health authorities have been trying to crack down on counterfeit prescription drugs. But on a new United Kingdom website the world's biggest drug company, Pfizer, is apparently taking the fight against knockoffs to a whole nutha level.
Dr. Steven Nissen, the cardiology chief at the Cleveland Clinic, reportedly remains on the shortlist to possibly become the next FDA Commissioner. Some analysts believe if Dr. Nissen gets the nod there could be a negative knee-jerk reaction in the big pharma sector stocks.
Even before they have settled into their new jobs, President Obama’s economic team faces an acute crisis in the nation’s banking system that has no easy answers and that they are not yet prepared to address, the New York Times reported.
Dow component and giant healthcare company--you really can't lump it in with big pharma because it sells drugs, medical devices and consumer products--Johnson & Johnson reported earnings this morning.
The UnitedHealth settlement over out-of-network medical costs has huge implications for all of us. For one, it shows that the consumer can still effect change.
Consumer prices may be falling, but what does it matter when health care costs are skyrocketing?
Even though it's one of the leading causes of cancer death in the U.S., pancreatic normally doesn't get much attention.
A recession means making tough money decisions. But for some, it quite literally means the difference between life and death.
And that's not all. Energy plays, housing stocks, retailers – they're all victims of an under-the-radar trend in the markets.
Even if you're insured, you are not immune from sky-high medical bills. One cancer patient found out the hard way - and did something about it.
I couldn't go to the formal, scripted Genentech presentation at the JPMorgan Healthcare Conference yesterday afternoon because I was busy doing the crazy interview on "Fast Money" with the CEO of athenahealth, Jonathan Bush. I've never done a CEO interview like it.
Insurance companies take care of their bottom line before they worry about taking care of you. Here's what to know to make sure you aren't being taken for a ride.
More and more seemingly law-abiding citizens are torching their cars, reporting them stolen and filing insurance claims. And it's affecting all of us.
During his lunchtime keynote speech here at the JPMorgan Healthcare Conference JPM Chairman and CEO Jamie Dimon was asked to give his worst-case scenario for the economy. He said that'd be a 1982-type recession lasting about two years and with unemployment "North of 10 percent." Dimon said it would be "Irrational to not be prepared for that."
We haven’t heard that phrase since Lehman Brothers imploded. Wonder why.
Not surprisingly it was standing room only in the grand ballroom of the Westin St. Francis Hotel in San Francisco for the Roche presentation this morning at the JPMorgan Healthcare Conference.
I'm covering the 27th Annual JPMorgan Healthcare Conference in San Francisco where I suspect there will be a big crowd for the Roche presentation later this morning. It's being reported that the Swiss drugmaker may soon raise its bid for Genentech. I'll be shocked if Roche says much about it either in the formal presentation or breakout session. But I'll be there just in case.
Get the best of CNBC in your inbox